Taehyung Yu

Taehyung Yu

Auto-generated profile, based on publicly available information

Taehyung Yu

Biosignal R&D Team, VUNO Inc. , Seoul

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

11 June 2026 in European Heart Journal - Digital Health
Verified
Journal Article
Open access
MKMyoung Jung Kim
Myoung Jung Kim
SESujeong Eom
Sujeong Eom
JKJuwon Kim
Juwon Kim
SPSeung-Jung Park
Seung-Jung Park
KPKyoung-Min Park
Kyoung-Min Park
JKJu Youn Kim
Ju Youn Kim
Aims: Consumer-grade electrocardiogram (ECG) devices enable accessible rhythm monitoring. Recently developed six-lead handheld ECGs promise improved signal quality and diagnostic performance; however, comparative validation remains limited. Using 12-lead ECGs as reference, we compared diagnostic performance and quantitative agreement of a 6-lead and single-lead consumer ECGs. Methods and results: In this prospective single-centre study, 194 arrhythmia-clinic patients (498 paired recordings) underwent simultaneous 10-s 12-lead and 30-s 6-lead ECG acquisition, followed by sequential 30-s single-lead recording. Two blinded electrophysiologists interpreted ECGs. Diagnostic performance for predefined rhythm categories (sinus rhythm, atrial/ventricular premature complex, atrial fibrillation/flutter/tachycardia, atrioventricular block, others) was assessed by sensitivity, specificity, and accuracy. Waveform agreement was evaluated using Bland–Altman analysis and intraclass correlation coefficients (ICC) accounting for repeated measures. Sensitivity was higher for the 6-lead ECG for ectopic beats, atrial flutter, and first-degree atrioventricular block, with comparable specificity across categories. Overall diagnostic accuracy was 98.6% (95% confidence interval, 97.4–99.6) for the 6-lead and 96.9% (94.7–98.7) for the single-lead ECG. Agreement with the 12-lead ECG was higher for the 6-lead device for PR interval (ICC 0.89; 0.85–0.92) and QRS amplitude (0.96; 0.94–0.97) than for the single-lead device (0.57; 0.48–0.63 and 0.04; −0.13–0.21, respectively). Bland–Altman analysis demonstrated generally narrower limits of agreement for the 6-lead ECG. Findings were consistent in patient-level sensitivity analyses. Conclusion: The 6-lead handheld ECG demonstrated a higher point estimate for diagnostic accuracy and closer agreement with the 12-lead ECG than the single-lead smartwatch ECG, supporting its use for arrhythmia assessment and interval measurement.